Key facts
- This page summarizes Peter Westley's Form 4 filing for CuriosityStream Inc. (CURI).
- 4 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 01 Aug 2023, 15:48.
Peter Westley - 28 Jul 2023 Form 4 Insider Report for CuriosityStream Inc. (CURI)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- CURI
- Reported as of
- 28 Jul 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Aug 2023, 15:48:04 UTC
- Prior SEC filing
- 05 Jun 2023
- Next SEC filing
- 07 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Marianna Shelenkova as attorney-in-fact for Peter Westley
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Peter Westley filed Form 4 for CuriosityStream Inc. (CURI) on 01 Aug 2023.
Change
- Previous filing in this sequence was filed on 05 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CURI
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- Shares
- +44,249
- Change %
- Price
- Shares after
- 44,249
- Date
- 28 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 44,249
- Exercise price
- Footnotes
- F1, F2
CURI
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- Shares
- +134,813
- Change %
- Price
- Shares after
- 134,813
- Date
- 28 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 134,813
- Exercise price
- Footnotes
- F1, F3
CURI
transaction
Derivative
Stock Options (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -50,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 28 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $2.32
- Footnotes
- F1, F4
CURI
transaction
Derivative
Stock Options (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -221,904
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 28 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 221,904
- Exercise price
- $1.62
- Footnotes
- F1, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Pursuant to the Company's cancellation of certain "underwater" stock options granted to employees and executive officers and replacement thereof with restricted stock units ("RSUs") (the "Option Cancellation and Exchange"), on July 28, 2023, the Compensation Committee of the Board of Directors of the Company approved the cancellation of Mr. Westley's options to purchase 271,904 shares of common stock, granted under the Company's 2020 Omnibus Incentive Plan (the "Plan"), and granted Mr. Westley RSUs of approximately equal fair value of the cancelled stock options, valued as of July 14, 2023.
Footnote F2
On July 28, 2023, pursuant to the Option Cancellation and Exchange, in exchange for Mr. Westley's fully vested cancelled stock options, the Company granted Mr. Westley 44,249 RSUs under the Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs granted will vest on July 28, 2024.
Footnote F3
On July 28, 2023, pursuant to the Option Cancellation and Exchange, in exchange for Mr. Westley's unvested cancelled stock options, the Company granted Mr. Westley 134,813 RSUs under the Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs granted will vest as follows: 23,502 shares in equal increments on April 22, 2024, April 22, 2025 and April 22, 2026; and 111,311 shares in equal increments on May 21, 2024, May 21, 2025, and May 21, 2026.
Footnote F4
Includes unvested option to purchase 37,500 shares of the Company's common stock, which would have vested annually until April 22, 2026.
Footnote F5
Includes unvested option to purchase 166,428 shares of the Company's common stock, which would have vested annually until May 21, 2026.